Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Oral rigosertib shows promise as a therapy for myelodysplastic syndrome

Dec. 27, 2011

Phase I study evaluates SCH-900776/cytarabine combination for leukemia

Dec. 27, 2011

Phase II ARRY-520 trial in multiple myeloma yields encouraging results

Dec. 27, 2011

New hepcidin inhibitor exhibits antianemic effects in vivo

Dec. 27, 2011

Kissei presents new nonpurine adenosine A2A receptor antagonists

Dec. 23, 2011

U.K. study uncovers new biomarker for bronchiolitis obliterans syndrome

Dec. 23, 2011

Biomarkers of kidney injury identified in patients with MM

Dec. 23, 2011

VANTAGE 88 reveals activity of combination therapy for multiple myeloma

Dec. 23, 2011

Phase I trials evaluate candidate prime-boost malaria vaccine regimen in healthy adults and children

Dec. 22, 2011

Large-scale phase III trial assesses ChimeriVax-Dengue vaccine in Singapore

Dec. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...